Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Dilated Cardiomyopathy: Discovery Of Novel Gene
Researchers in the Heart Institute at Cincinnati Children"s Hospital Medical Center have discovered a novel gene responsible for heart muscle disease and chronic heart failure in some children and adults with dilated cardiomyopathy (DCM).
generic viagra online
Navigation In Hip Resurfacing
Hip resurfacing can be a good alternative to total hip replacement (THR) in young adults because it conserves bone and it has acceptable short- to medium-term results. However, there have been concerns about fractures of the femoral neck with this procedure, partly due to notching and varus alignment during implantation.
News of the day
Long-Term Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World Clinical Practice
The first results from the Medtronic Inc., (NYSE: MDT) OMNI Study were released at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, revealing that one out of six patients with implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillators (CRT-Ds) to prevent sudden cardiac arrest (SCA), received potentially life-saving medical therapy - either in the form of anti-tachycardia pacing (ATP) or a shock for dangerously fast heart rhythms - within a period of two years following their implant. Further, the study showed that patients received therapy at similar rates, regardless of whether they meet current medical society guidelines.
Medical Devices

HearAtLast To Launch Exclusive Groundbreaking Neuro-CompensatorTM Technology Hearing Aids From VitaSound

HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced that in keeping with its tradition of bringing innovative new products to consumers, the Company announces the unveiling of breakthrough hearing products based on the Neuro-Compensator™ algorithm technology from VitaSound Audio. The NEURO-COMPENSATOR™ hearing instruments are powered by the newest groundbreaking neuro-biological technology designed to optimize the auditory nerve output. Based on many years of research at McMaster University into the electrical signals that are transmitted to the brain by the auditory nerves in healthy and impaired ears, this patented technology is designed to significantly improve the perceived audio quality in hearing devices. Using standard audiometric test data, the algorithm engine derives a customized map of an individual"s auditory system and configures the hearing device to optimize auditory nerve output for that individual. Clarity of sound, perception of true pitch, and more normal perception of own voice are just some of the benefits noted by trial subjects. "Neuro-Compensation represents a unique Canadian story from research at McMaster University, development at VitaSound, to market launch at our retail locations in Wal-Mart Canada stores," said Matthew Sacco, CEO of HearAtLast. "This underscores our commitment to being first to bring innovative new technologies to consumers." Available first in Canada exclusively at selected HearAtLast locations in mid-April, products will be generally available throughout the chain by the end of May. About VitaSound VitaSound"s mission is to develop and bring to market hearing solutions that are unique and innovative, but also accessible and affordable, to enable all individuals to benefit from better communications and quality of life. We focus on total hearing healthcare which involves protection, preservation, care and improvement, all in the context of today"s active lifestyles. For more information on VitaSound Audio, Inc., please visit: http://www.vitasound.com HearAtLast


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009